The inhibition of myostatin signalling by anti‐myostatin antibodies or activin receptor inhibitors seems to be a great challenge to increase muscle mass in case of muscle wasting diseases, for example cancer‐associated cachexia, age‐related sarcopenia or plaster cast immobilization 53. This evidence concerns the gene MSTN and sarcopenia.